Resources

Liz Bloss
DVM, a regulatory leader with more than 25 years of experience in the industry. She has a strong track record and broad expertise leading and delivering products from early development (IND) through market approval in various therapeutic areas with focus on oncology. She is an exceptional cross-functional leader, bridging discipline and organizational boundaries to build committed teams delivering innovative solutions with complex submissions and/or regulatory authority review times with high quality and in compressed timelines.
Recent Posts

FDA Guidance States Once Again that ClinicalTrials.gov Reporting will be Enforced

Liz Bloss

The Public Weighs in on Improving ClinicalTrials.gov

Liz Bloss

Save Time and Money in Developing Your New Drug. Leverage Section (b)(2) Where Possible

Liz Bloss

A Quick Look at the Ongoing FDA Reorganization

Liz Bloss

Are You Ready to Meet Your Advisory Committee?

Liz Bloss

The FDA Adjusts Operations in Response to Coronavirus Concerns

Liz Bloss

Is Your Clinical Trial in Compliance with ClinicalTrials.gov (If Not, It Could Cost You)

Liz Bloss

A Few Tips on Labeling Development for Success

Liz Bloss

What You Need to Know About FDA Pre-IND Meetings

Liz Bloss

Is Your IND, NDA, or BLA on the OND's List?

Liz Bloss
CONTACT US

Ask us anything.

We would be delighted to hear from you and discuss our consulting services. Please call +1 215 648 1208 to chat with us directly. Or write to us using the form provided here. We look forward to collaborating with you.